Ackman raises stake in Valeant Pharma

Nov 23 (Reuters) - Bill Ackman's Pershing Square Capital Management raised its stake in Valeant Pharmaceuticals International Inc to 9.9 percent, making it the second largest shareholder in the company.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.